Skip to the main content.

A Global CDMO Providing Innovative Biologic Solutions

KBI is Redefining Contract, Comprehensive, Cutting-Edge, Collaborative, Complete, Consistent, Compliant, Critical, Continuous, Connected, Cohesive, Capable

Development and Manufacturing Services for New Biologics


With a solid foundation in analytics combined with our best-in-class cell line development (CLD) platform, KBI provides vertically integrated services for First in Human (FIH) programs from CLD through to commercial manufacturing.

Explore Mammalian >>

MicrosoftTeams-image (91)


More molecules are manufactured using an E. Coli expression system than ever before thanks to reimagined platforms, efficiency gains, and broader-based applicability. KBI is raising the bar on microbial expression and manufacturing, using an early optimization workflow to ensure manufacturing success. 

Explore Microbial >>

MicrosoftTeams-image (90)


Our extensive process and analytical development capabilities cover all stages, supporting early-stage development through small-scale protein production to fully-integrated, comprehensive process optimization leading to GMP manufacturing. 

Explore Analytical >>

MicrosoftTeams-image (89)

Cell Therapy 

Our team of experts has extensive experience in all aspects of cell therapy, from early-stage process development to clinical trial support and cGMP manufacturing. We combine our deep knowledge to deliver unmatched value to our customers.

Explore Cell Therapy >>

MicrosoftTeams-image (92)

Ready to Learn More? Get in Touch with our Team.


Contact Us



Never Miss Another Update! 

Subscribe to KBI's Newsletter, The Pulse, to stay up-to-date on all the latest news, articles, and events from KBI Biopharma.